China is considering new export restrictions on advanced technologies, including, in particular, in the life sciences sectors. In late December 2022, China’s Ministry of Commerce (“MOFCOM”) issued the proposed amendment to...more
3/23/2023
/ Biopharmaceutical ,
Biotechnology ,
China ,
CRISPR ,
DNA ,
Export Controls ,
Genetic Materials ,
Genetic Testing ,
Life Sciences ,
MInistry of Commerce ,
Technology
When does an applicant have “enough” to file a patent application and be granted a patent?
That question continues to dog applicants in the biopharmaceutical industry, particularly in view of recent Federal Circuit...more